Holen Sie sich die Stockscreener-App
23.05
0.71%
0.425
Apellis Pharmaceuticals Inc Aktie (APLS) Neueste Nachrichten
Apellis Pharmaceuticals: Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders - Seeking Alpha
Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - MSN
Volume spikes in Apellis Pharmaceuticals Inc. stock – what they meanJuly 2025 Intraday Action & Long-Term Investment Growth Plans - newser.com
What drives Apellis Pharmaceuticals Inc stock priceInstitutional Buying Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in
H.C. Wainwright reiterates Buy rating on Apellis Pharmaceuticals stock By Investing.com - Investing.com Canada
Apellis Pharmaceuticals CFO sells $16,119 in stock - MSN
Published on: 2025-09-29 15:38:29 - newser.com
What MACD and RSI say about Apellis Pharmaceuticals Inc.Weekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Can Apellis Pharmaceuticals Inc. stock surprise with earnings upsideQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Smart tools for monitoring Apellis Pharmaceuticals Inc.’s price actionJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com
Using R and stats models for Apellis Pharmaceuticals Inc. forecasting2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
What Fibonacci levels say about Apellis Pharmaceuticals Inc. reboundQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
Apellis Pharmaceuticals, Inc. $APLS Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Why retail investors pile into Apellis Pharmaceuticals Inc. stockOptions Play & Scalable Portfolio Growth Ideas - newser.com
How to monitor Apellis Pharmaceuticals Inc. with trend dashboardsTrade Exit Report & Fast Exit Strategy with Risk Control - newser.com
Goldman Sachs downgrades Apellis stock to Sell on Syfovre growth concerns By Investing.com - Investing.com Nigeria
12 Analysts Assess Apellis Pharmaceuticals: What You Need To Know - Benzinga
Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) with Low - GuruFocus
Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) Amid Com - GuruFocus
Apellis down as Goldman Sachs cuts to sell on risks to outlook - MSN
Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down After Analyst Downgrade - MarketBeat
Apellis stock cut to sell at Goldman Sachs (APLS:NASDAQ) - Seeking Alpha
Apellis Pharmaceuticals (NASDAQ:APLS) Lowered to Sell Rating by The Goldman Sachs Group - MarketBeat
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market SessionApellis Pharmaceuticals (NASDAQ:APLS), Concentrix (NASDAQ:CNXC) - Benzinga
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket - Benzinga
Goldman Sachs Downgrades Apellis Pharmaceuticals to Sell From Neutral, Adjusts PT to $18 From $26 - MarketScreener
Goldman Sachs downgrades Apellis stock to Sell on Syfovre growth concerns - Investing.com
Fierce Biotech Layoff Tracker 2025: IO lays off 50% of employees; Heidelberg reduces headcount by 75% - Fierce Biotech
Apellis Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Pallas Capital Advisors LLC Has $949,000 Stock Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
Apellis Pharmaceuticals (NASDAQ:APLS) Director Sells $713,561.40 in Stock - MarketBeat
Zacks Research Has Bullish Estimate for APLS FY2025 Earnings - MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Apellis Pharmaceuticals (NASDAQ:APLS) General Counsel Sells $121,700.00 in Stock - MarketBeat
Setup Watch: Should I invest in ATMV before earningsTreasury Yields & Fast Moving Stock Watchlists - khodrobank.com
Dunlop A. Sinclair sells Apellis (APLS) shares worth $713k - Investing.com
Goldman Sachs Group Inc. Has $6.73 Million Stake in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
Apellis Pharma director Dunlop sells $713,561 in shares By Investing.com - Investing.com Canada
Apellis Pharma director Dunlop sells $713,561 in shares - Investing.com India
Dunlop A. Sinclair sells Apellis (APLS) shares worth $713k By Investing.com - Investing.com South Africa
Can volume confirm reversal in Apellis Pharmaceuticals Inc.Forecast Cut & Daily Technical Forecast Reports - newser.com
Evaluating Apellis Pharmaceuticals Inc. with trendline analysisJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Stock Market Recap: Will Apellis Pharmaceuticals Inc benefit from rising consumer demand2025 Market Outlook & AI Driven Price Predictions - خودرو بانک
Key resistance and support levels for Apellis Pharmaceuticals Inc.2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - newser.com
Best data tools to analyze Apellis Pharmaceuticals Inc. stockTrade Risk Assessment & Reliable Price Action Trade Plans - newser.com
1.35%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):